Iterum Therapeutics Plc (ITRM)
0.421
-0.03
(-6.44%)
USD |
NASDAQ |
Dec 15, 16:00
0.4239
0.00 (0.00%)
After-Hours: 20:00
Iterum Therapeutics Cash from Investing (Quarterly): -0.0126M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alkermes Plc | -6.737M |
| Amarin Corp. Plc | -12.29M |
| Jazz Pharmaceuticals Plc | -327.80M |
| Prothena Corp. Plc | -0.0114M |
| GH Research Plc | 10.44M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.848M |
| Cash from Financing (Quarterly) | 5.658M |
| Free Cash Flow | -19.62M |
| Free Cash Flow Per Share (Quarterly) | -0.1716 |
| Free Cash Flow to Equity (Quarterly) | -9.037M |
| Free Cash Flow to Firm (Quarterly) | -7.290M |
| Free Cash Flow Yield | -127.3% |